Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Molecular Imaging and Biology|January 22, 2021
Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [<sup>11</sup>C]MetoclopramideMartin Bauer, Sandra Barna, Matthias Blaickner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 2018
Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PETViktoria Zoufal, Thomas Wanek, Markus Krohn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 24, 2018
Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in miceSeverin Mairinger, Viktoria Zoufal, Thomas Wanek, et al.
European Journal of Pharmacology|October 2, 2012
Interaction of HM30181 with P-glycoprotein at the murine blood-brain barrier assessed with positron emission tomographyFlorian Bauer, Thomas Wanek, Severin Mairinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman PrimatesNicolas Tournier, Sebastien Goutal, Sylvain Auvity, et al.
Alzheimer'S Research & Therapy|October 17, 2021
Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labelingThomas Filip, Severin Mairinger, Joerg Neddens, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
Epilepsy Research|February 21, 2012
The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography studySeverin Mairinger, Jens P Bankstahl, Claudia Kuntner, et al.
Cell Reports. Medicine|June 19, 2024
The impact of ATP-binding cassette transporters in the diseased brain: Context mattersChrysiida Baltira, Eleonora Aronica, William F Elmquist, et al.
Nuclear Medicine and Biology|June 19, 2013
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in ratsJulia Müllauer, Rudolf Karch, Jens P Bankstahl, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Molecular Imaging and Biology|January 22, 2021
Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [<sup>11</sup>C]MetoclopramideMartin Bauer, Sandra Barna, Matthias Blaickner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 2018
Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PETViktoria Zoufal, Thomas Wanek, Markus Krohn, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 24, 2018
Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in miceSeverin Mairinger, Viktoria Zoufal, Thomas Wanek, et al.
European Journal of Pharmacology|October 2, 2012
Interaction of HM30181 with P-glycoprotein at the murine blood-brain barrier assessed with positron emission tomographyFlorian Bauer, Thomas Wanek, Severin Mairinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman PrimatesNicolas Tournier, Sebastien Goutal, Sylvain Auvity, et al.
Alzheimer'S Research & Therapy|October 17, 2021
Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labelingThomas Filip, Severin Mairinger, Joerg Neddens, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
Epilepsy Research|February 21, 2012
The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography studySeverin Mairinger, Jens P Bankstahl, Claudia Kuntner, et al.
Cell Reports. Medicine|June 19, 2024
The impact of ATP-binding cassette transporters in the diseased brain: Context mattersChrysiida Baltira, Eleonora Aronica, William F Elmquist, et al.
Nuclear Medicine and Biology|June 19, 2013
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in ratsJulia Müllauer, Rudolf Karch, Jens P Bankstahl, et al.
Pageof 16